Business
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds
WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company";
About this update from Moolec Science Sa
WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced a significant scientific breakthrough in the production of animal proteins in plants.Through a sponsored research project with one of the most prestigious academic institutions in the United States of America, Moolec has successfully demonstrated the stable expression of bovine myoglobin, a heme-containing protein, within the seeds of the common pea (Pisum sativum).Platform Expansion: A New Crop, A Larger OpportunityThis 28-month research project represents the first reported case of producing bovine myoglobin in pea seeds, marking a significant expansion of Moolec's molecular farming platform beyond its current crop base.Key achievements include:Stable expression across generations, confirming reproducibility and genetic stabilitySuccessful deployment of proprietary constructs in a new legume crop, validating platform flexibilityEstablishment of pea seeds as a viable production system for high-value recombinant proteinsThis milestone reinforces Moolec's ability to systematically expand molecular farming across multiple crops, unlocking new pathways for scalable protein production.From Scientific Proof to Scalable Value CreationPea is a globally relevant, protein-rich crop with established supply chains and industrial adoption, making it a highly attractive platform for the production of animal-derived ingredients. By combining this expanding innovation pipeline with its recent operational progress, Moolec continues to position itself as a company capable of delivering both execution and continuous technological advancement, a critical driver of long-term value creation."This is not just a scientific milestone; it is a clear signal of the scalability and versatility of our platform. Successfully expressing a heme protein in pea is a powerful validation of our ability to expand our technology across crops and product categories. This is how we build a pipeline, not just a product, and how we translate innovation into long-term, scalable value for our shareholders," said Alejandro Antalich, CEO of Moolec Science.The research was conducted under a sponsored re...